<DOC>
	<DOCNO>NCT02858180</DOCNO>
	<brief_summary>This multicenter study Hepatitis C Virus ( HCV ) infect adult patient also advance cardiac disease advance lung disease .</brief_summary>
	<brief_title>Hepatitis C Virus ( HCV ) Heart Lung Study</brief_title>
	<detailed_description>This multicenter study HCV infect adult patient also either advanced cardiac disease , advance lung disease . Advanced cardiac disease define marked limitation physical activity , discomfort upon physical activity . The patient advance cardiac disease group must also hospitalize heart failure within last 12 month . Advanced lung disease define patient diagnosed chronic obstructive pulmonary disease ( COPD ) interstitial lung disease ( ILD ) . Patients COPD group must abnormalities forced expiratory volume ( FEV ) test , measure amount air exhale . They may may need supplemental oxygen . Patients ILD group must diagnose ILD require supplement oxygen time .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Ledipasvir</mesh_term>
	<mesh_term>Ledipasvir , sofosbuvir drug combination</mesh_term>
	<criteria>Chronic HCV Infection Genotype 1 , 4 , 5 , 6 HCV RNA &gt; 103 IU/mL screen 18 year age old Diagnosis chronic HCV infection , define positive HCV antibody HCV RNA 6 month prior screen OR assessment fibrosis F2 great prior screening . Subjects advance heart failure cohort must meet HCV criterion , follow criterion : New York Heart Association ( NYHA ) Class III IV functional classification NYHA Class III : Subjects cardiac disease result marked limitation physical activity . They comfortable rest . Less ordinary physical activity cause fatigue , palpitation , dyspnea , anginal pain . NYHA Class IV : Patient cardiac disease result inability carry physical activity without discomfort . Symptoms cardiac insufficiency anginal syndrome may present even rest . If physical activity undertaken , discomfort increase . ejection fraction ≤ 30 % hospitalized heart failure last 12 month Subjects advance lung disease cohort must diagnose chronic obstructive pulmonary disease ( COPD ) interstitial lung disease ( ILD ) must meet HCV criterion , meet follow criterion COPD ILD : ILD criterion : diagnosis interstitial lung disease chronic supplemental oxygen requirement rest and/or exertion . COPD criterion ( one follow ) : Forced expiratory volume ( FEV1 ) &lt; 30 % predict OR FEV1 chronic supplemental oxygen requirement rest and/or exertion OR FEV1 chronic hypercapnia ( baseline partial pressure arterial carbon dioxide [ PaCO2 ] &gt; 45 ) Chronic HCV Infection Genotype 2 3 Treatment follow agent Amiodarone . Subjects previously treat amiodarone must stop amiodarone least 60 day prior day 1 SOF/LDV FDC Carbamazepine , phenytoin , phenobarbital , oxcarbazepine Rifabutin , rifampin rifapentine HIV regimens contain tenofovir tipranavir/ritonavir St. John 's wort Rosuvastatin Have serious active medical psychiatric illness , opinion investigator , would interfere subject treatment , assessment , compliance History hepatic encephalopathy variceal hemorrhage Hepatitis B surface antigen positive Abnormal hematological biochemical parameter , include : Hemoglobin ( Hb ) &lt; 8 g/dL Platelets ≤ 50,000/mm3 alanine aminotransferase ( ALT ) , aspartase aminotransferase ( AST ) , alkaline phosphatase ≥ 10 time upper limit normal ( ULN ) Total bilirubin &gt; 3 mg/dl Severe renal impairment creatinine clearance ( CrCl ) , i.e . &lt; 30 mL/min . History major organ transplantation exist functional graft . History clinicallysignificant drug allergy nucleoside/nucleotide analog . Pregnant woman woman plan become pregnant Women breastfeed Active recent history ( ≤ 1 year ) drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>